June 4, 2020
The global pharma market reached US$1,134.7 billion in 2019, expanding 5.7% over the previous year with the exclusion of currency fluctuations, with AbbVie’s rheumatoid arthritis drug Humira (adalimumab) retaining the best-selling crown, according to the latest report released by IQVIA...read more